Jeffrey A. Bluestone

University of Chicago, Chicago, IL 
Cell Biology, Immunology, Molecular Biology
"Jeffrey Bluestone"


Sign in to add trainee
Maria-Luisa Alegre grad student Chicago
Ingrid C. Rulifson grad student 2000 Chicago
Keshava Rajagopal grad student 2001 Chicago
Cristina Penaranda grad student 2005-2010 UCSF (Microtree)
Anne I Sperling post-doc (Neurotree)
Leonardo M.R. Ferreira post-doc 2016- UCSF
Daniel Bryan Goodman post-doc 2017- UCSF (Chemistry Tree)
Brian T. Fife post-doc 2002-2007 UCSF (Microtree)
Todd M. Brusko post-doc 2008-2011 (Epi Tree)
Gaurav Chopra post-doc 2013-2016 UCSF (Computational Biology Tree)


Sign in to add collaborator
Eugene P Brandon collaborator (Neurotree)
Yapeng Su collaborator (Chemistry Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bluestone JA, McKenzie BS, Beilke J, et al. (2023) Opportunities for Treg cell therapy for the treatment of human disease. Frontiers in Immunology. 14: 1166135
Goodman DB, Azimi CS, Kearns K, et al. (2022) Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies. Science Translational Medicine. 14: eabm1463
VanDyke D, Iglesias M, Tomala J, et al. (2022) Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection. Cell Reports. 41: 111478
Su Y, Yuan D, Chen DG, et al. (2022) Multiple early factors anticipate post-acute COVID-19 sequelae. Cell
Balcerek J, Shy BR, Putnam AL, et al. (2021) Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience. Frontiers in Immunology. 12: 744763
Muller YD, Ferreira LMR, Ronin E, et al. (2021) Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance. Frontiers in Immunology. 12: 686439
Dong S, Hiam-Galvez KJ, Mowery CT, et al. (2021) The effects of low-dose IL-2 on Treg adoptive cell therapy in patients with Type 1 diabetes. Jci Insight
Muller YD, Nguyen DP, Ferreira LMR, et al. (2021) The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28. Frontiers in Immunology. 12: 639818
Su Y, Chen D, Yuan D, et al. (2020) Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell
Lee JC, Mehdizadeh S, Smith J, et al. (2020) Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Science Immunology. 5
See more...